Prognostic value of the lactate-to-albumin ratio for mortality in patients with sepsis: A systematic review and meta-analysis
Authors' conclusion
Elevated LAR is associated with increased mortality and demonstrated moderate-to-good discriminative performance across multiple mortality outcomes in sepsis. Given its simplicity, low cost, and widespread availability, LAR may serve as a useful adjunct for early risk stratification.
Study context
- Population
- Patients with sepsis
- Participants
- 9,838 patients23 studies
- Comparison
- Elevated lactate-to-albumin ratio (LAR) and mortality
- Outcome
- ICU mortality
Methodological detailsPRISMA guidelines, preregistered on PROSPERO
- PRISMA guidelines
- Preregistered on PROSPERO
Pooled result
As reported in the abstract
ICU mortality
Elevated LAREstimate (95% CI)P value
I2 = 0.02%
HR 1.24(1.02–1.51)
P = 0.04I2 = 76.08%
OR 2.52(1.10–5.76)
P = 0.03Further pooled results
Overall mortality
| OR (95% CI) | P value | ||
|---|---|---|---|
| Elevated LARI2 = 0% | 2.25 (1.72–2.95) | P < 0.01 | |
| 0.20.5125Odds ratio (log scale) |
Pooled AUC of LAR
- 28-day mortality: AUC (95% CI 0.66-0.83; p < 0.01; I2 = 90%)
- 0.76
- ICU mortality: AUC (95% CI 0.60-0.90; p = 0.01; I2 = 95.3%)
- 0.79
- In-hospital mortality: AUC (95% CI 0.59-0.94; p = 0.02; I2 = 95%)
- 0.82
Original publication
Prognostic value of the lactate-to-albumin ratio for mortality in patients with sepsis: A systematic review and meta-analysis. J Crit Care. Published 13 November 2026. doi:10. 1016/ j. jcrc. 2026. 155804
Composed by AI from the published abstract and checked against it. How Briefs are made →